North American Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

North American Management’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-1,589	Closed	-$91K	–	141
2014 Q2	$91K	Sell	1,589 -1,589	-50%	-$80.7K	0.01%	140
2014 Q1	$126K	Sell	3,178 -1,271	-29%	-$54.4K	0.02%	143
2013 Q4	$187K	Hold	4,449	–	–	0.03%	131
2013 Q3	$133K	Sell	4,449 -1,271	-22%	-$44.5K	0.03%	123
2013 Q2	$303K	Buy	+5,720	New	+$251K	0.06%	106

Other funds holding MACK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

North American Management's MACK Position: Q3 2014 in Review

North American Management sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2014, closing a stake of 1,589 shares — an estimated $91K sold.

North American Management first reported a position in MACK in Q2 2013 and held it in 5 quarters. The position peaked at $303K in Q2 2013. 132 funds tracked by Wall St. Rank hold MACK as of Q3 2014.

North American Management reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q3 2014 after selling out during the quarter.
North American Management sold 1,589 Merrimack Pharmaceuticals, Inc. shares in Q3 2014, an estimated $91K.
North American Management first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 5 quarters.
North American Management's Merrimack Pharmaceuticals, Inc. position peaked at $303K in Q2 2013.
132 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2014.

Based on North American Management's 13F filing for Q3 2014, filed 3 Nov 2014.